Study Overview
Study Details
- Title: A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults
- Authors: Chandrasekhar K, Kapoor J, Anishetty S
- Journal: Indian Journal of Medical Research
- Year: 2012
- PubMed ID: 23125505
Key Results
- Cortisol Reduction: 27.9% decrease
- Stress Score Improvement: 44% reduction
- Anxiety Reduction: Significant improvement
- Safety: Well-tolerated with no adverse effects
- Duration: 60 days
Study Background and Significance
This landmark study by Chandrasekhar and colleagues represents one of the most comprehensive and well-designed clinical trials examining ashwagandha's effects on stress and cortisol levels. Published in the prestigious Indian Journal of Medical Research, this research has become a cornerstone reference for ashwagandha's stress-reducing properties.
Study Design and Methodology
Participants
The study included 64 adults (aged 18-54 years) with a history of chronic stress. Participants were carefully screened to ensure they met specific stress criteria and were free from major medical conditions that could interfere with the results.
Study Design
- Type: Randomized, double-blind, placebo-controlled trial
- Duration: 60 days
- Groups: Ashwagandha group (n=32) and placebo group (n=32)
- Dosage: 300mg twice daily (600mg total daily dose)
- Extract: High-concentration full-spectrum ashwagandha root extract
Outcome Measures
The researchers used multiple validated assessment tools:
- Perceived Stress Scale (PSS): Standardized questionnaire measuring stress levels
- Depression Anxiety Stress Scale (DASS-21): Comprehensive mood assessment
- Serum Cortisol: Morning cortisol levels measured via blood tests
- General Health Questionnaire (GHQ-28): Overall well-being assessment
Key Findings and Results
Cortisol Reduction
The most striking finding was the significant reduction in serum cortisol levels:
- Ashwagandha group: 27.9% reduction in morning cortisol levels
- Placebo group: No significant change
- Statistical significance: p < 0.001, indicating extremely strong evidence
Perceived Stress Improvement
Participants taking ashwagandha experienced dramatic improvements in stress perception:
- PSS scores: 44% improvement compared to baseline
- Placebo comparison: Significantly better than placebo group
- Clinical relevance: Improvements were both statistically and clinically significant
Anxiety and Mood Benefits
The DASS-21 assessment revealed significant improvements in:
- Anxiety levels
- Depression scores
- Overall stress ratings
- General psychological well-being
Safety and Tolerability
The study demonstrated excellent safety and tolerability:
- Adverse events: No serious adverse events reported
- Side effects: Minimal and comparable to placebo
- Laboratory parameters: No clinically significant changes
- Compliance: High participant compliance throughout the study
Clinical Implications
Mechanism of Action
The study's results support ashwagandha's classification as an adaptogen by demonstrating its ability to:
- Normalize HPA (hypothalamic-pituitary-adrenal) axis function
- Reduce excessive cortisol production
- Improve stress resilience and adaptation
- Support overall psychological well-being
Practical Applications
The findings suggest that ashwagandha supplementation may be beneficial for:
- Individuals with chronic stress
- People with elevated cortisol levels
- Those seeking natural stress management solutions
- Individuals with stress-related health concerns
Study Strengths
- Rigorous design: Double-blind, placebo-controlled methodology
- Objective measures: Biochemical cortisol testing alongside subjective assessments
- Adequate duration: 60-day study period allows for meaningful adaptation
- Validated tools: Use of standardized, validated assessment instruments
- Statistical power: Sufficient sample size for meaningful conclusions
Limitations and Considerations
- Population: Study focused on adults with chronic stress; results may vary in other populations
- Duration: Long-term effects beyond 60 days were not assessed
- Dosage: Only one dosage level was tested
- Geographic scope: Single-center study in India
Conclusion
This landmark study provides compelling evidence for ashwagandha's effectiveness in reducing stress and cortisol levels. The 27.9% reduction in cortisol and 44% improvement in perceived stress represent clinically meaningful benefits that support ashwagandha's traditional use as an adaptogenic herb.
The study's rigorous methodology, significant results, and excellent safety profile make it a cornerstone reference for ashwagandha's stress-reducing properties. These findings have been replicated and extended by subsequent research, further validating ashwagandha's role in stress management.
Related Studies
Full Citation
Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Medical Research, 136(3), 404-411. PMID: 23125505. Available at: https://pubmed.ncbi.nlm.nih.gov/23125505/